Skip to main content
- COPD exacerbation risk falls with dry powder vs. metered-dose, soft mist inhaler 3/18/26
- Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says 3/16/26
- Strait of Hormuz standoff puts supply of America’s generic drug prescriptions at risk 3/16/26
- Lower-Carbon LAMA–LABA Inhalers Linked to Modest Reductions in COPD Exacerbation Risk 2/25/26
- Umeclidinium-Vilanterol Tied to Better Outcomes Than Other LAMA-LABA Inhalers in Symptomatic COPD 2/25/26
- Dry Powder Inhalers: A Double Win for COPD and the Environment 2/24/26
- Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access 12/9/25
- ATS Assembly on Pediatrics Advocacy Series Podcast: Policy Related Advocacy 12/8/25
- FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office 11/17/25
- The 340B Program: Examining Its Growth and Impact on Patients 10/23/25
- Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger 10/17/25
- Inhalers Harm the Planet and Your Patients. What to Do 10/14/25
- Is your inhaler causing climate pollution? 10/7/25
- Asthma, COPD Inhalers Contributing More Greenhouse Gases 10/7/25
- Inhalers produce as much carbon emissions as over 500,000 cars each year, study finds 10/7/25
- Climate pollution from inhalers has the impact of half a million cars per year, study finds 10/6/25
- Air Apparent: Patent Law Is Choking Inhaler Affordability 7/8/25
- The MATCH Monopoly: Evaluating the Medical Residency Antitrust Exemption 5/14/25
- COPD: Could there be a GLP-1 for that? 5/7/25
- Man dies of asthma attack after inhaler cost skyrockets to more than $500 2/10/25
- Study Compares Single-Inhaler Triple Therapies for Treatment of COPD 1/3/25
- Environmentally Friendlier COPD Inhaler May Also Be More Effective 12/30/24
- How ‘green’ inhalers could evade Biden’s drug pricing legacy 10/14/24
- A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down 7/17/24
- FTC opens investigation into Teva, escalating patent fight with pharma industry 7/1/24
- Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market 5/21/24
- Senators strike bipartisan tone on more pharma patent reforms 5/21/24
- Bernie Sanders may have reached the limits of his pharma pressure campaign 5/20/24
- Study identifies groups of people who mistrust the FDA 5/17/24
- Could better asthma inhalers help patients, and the planet too? 5/6/24
- Biden summons Bernie Sanders to help boost drug-price campaign 4/3/24
- A dispute over a common asthma drug leaves patients caught in the middle 2/19/24
- Still confused after Flovent discontinuation? What to know and do 2/16/24
- Makers of blockbuster weight loss drugs are using 'patent thickets' to protect products, Harvard study claims 2/5/24
- Diabetes treatments have improperly listed patents that should be removed, analysis finds 2/5/24
- Bernie Sanders, Senate Democrats open investigation into price of asthma inhalers 1/8/24
- Sanders targets high price of inhalers 1/8/24
- ‘A huge shock to the system’: Doctors warn about asthma inhaler switch coming in January 12/28/23
- How Drug Makers Manipulate Patents to Keep Insulin Prices High 11/17/23
- Insulin Delivery Device Patents Prolong Market Exclusivity 11/16/23
- FTC challenges more than 100 drug patents owned by AbbVie, AstraZeneca, Boehringer and seven others11/7/23
- How Patents Help Keep Obesity Drug Prices Sky-High 9/19/23
- Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says 9/14/23
- Generic, Brand-Name Medication Similarly Effective for COPD 8/7/23
- Generic Fluticasone–Salmeterol Inhaler for COPD Matches Branded Product 8/7/23
- Generic Inhalers for COPD Support Hold Their Own 8/7/23
- Real-World Data on COPD Combo Inhalers Favor LAMA-LABAs 5/23/23
- How the makers of inhalers keep prices so high 5/1/23
- Where are all the generic inhalers for asthma and COPD? Researchers call for patent and FDA reforms 3/7/23
- Here’s why there aren’t many cheap, generic versions of pricey inhalers 3/6/23
- Updated: Drugmakers benefit 'substantially' from secondary patents on inhalers — study 1/3/23
- Brand name inhalers are very good at blocking competition, better even than nebulizers, study finds 9/9/22
- Regulatory, Patent Reform Needed for Inhalers for Asthma, COPD 5/20/22
- Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds 5/17/22
- Pricy inhalers remain expensive due to device tweaks that keep competitors at bay, researchers find 5/17/22
- Hospitals charge insurers and cash-paying patients much more than what Medicare pays for some infused drugs 11/8/21
- A bitter pill: Biden suffers familiar defeat on prescription drug prices 10/29/21
- Covid-19 Crisis Forces California Hospitals to Plan Who Gets Life-Saving Care 1/8/21
- With growing usage and few generics, Medicare spending on inhalers is climbing 12/3/20
- Study: Medicare Could Save Billions on Insulin 2/3/20
- African-Americans are disproportionately enrolled in studies that don’t require informed consent 10/1/18
- Stroke Clinical Trial Recruitment Still a Challenge 2/9/17
- Stroke research trials struggle to get enough participants 1/30/17
